DAIC

MARCH 6, 2024

As Cleerly continues to develop cardiovascular innovations to support patients and healthcare professionals, we are honored to have received Breakthrough Device Designation and join the TAP Pilot,” said James K. Min , MD, Founder and CEO of Cleerly.

Heart Disease 105

Heart Disease Heart Attack Heart attacks Technology 105

DAIC

APRIL 1, 2024

“The concepts I wrote in this paper also form the crux of what we are doing here at the Center for Innovation at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. Is There Medication for Valvular Heart Disease?

Technology 105

Technology Heart Disease Innovation Ultrasound 105

DAIC

MARCH 5, 2024

FIRE1 seeks to transform heart failure management by enabling patients to monitor and control their fluid volume themselves with a consumer-friendly device at home, similar to how continuous glucose monitoring transformed diabetes care. and is the most common cause of hospitalization for those aged 65 and over.

Heart Failure 52

Heart Failure Innovation Hospital Technology 52

Cardiometabolic Health Congress

OCTOBER 10, 2024

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.

Innovation 52

Innovation Technology Kidney Disease Chronic Disease 52

Cardiometabolic Health Congress

AUGUST 14, 2024

This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Aronne, MD Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients Jay H. When I heard of his passing, I felt quite sad.

CME 72

CME Education Diabetes Innovation 72

DAIC

APRIL 30, 2024

The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

Frontiers in Cardiovascular Medicine

JANUARY 18, 2024

Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations. Exosomes from ASCs also play an indispensable role in this process.

Heart Disease 64

Heart Disease Myocardial Infarction Transplant Atherosclerosis 64

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

The British Journal of Cardiology

DECEMBER 3, 2024

These innovative agents, initially developed for glycaemic control in type 2 diabetes, have unexpectedly demonstrated significant cardiovascular benefits, revolutionising cardiologists’ approach to the prevention and treatment of heart failure and cardiovascular events.

Innovation 40

Innovation Heart Failure Diabetes Article 40

Cardiometabolic Health Congress

OCTOBER 25, 2024

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.

CME 64

CME Innovation Education Atherosclerosis 64

DAIC

JANUARY 18, 2024

This is an especially critical issue because many patients undergoing angioplasty procedures below the knee have diabetes and kidney dysfunction. The first-in-man experience represents a significant clinical milestone for Summa Therapeutics, a leading innovator in the cardiovascular medical device industry.

Angioplasty 105

Angioplasty Peripheral Arterial Disease Kidney Disease Laboratory 105

DAIC

FEBRUARY 14, 2025

Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. This is why we are passionate about pursuing alternatives to amputation for our patients.

Hospital 52

Hospital Peripheral Arterial Disease Cancer Innovation 52

CardiacWire

APRIL 10, 2024

Interventional Innovations – Interventional cardiology was the clear winner at ACC24, with numerous trials supporting an expanded role for interventional procedures across a wider range of conditions than we ever could have imagined five years ago.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Risk Factor Management: Controlling risk factors such as hypertension, diabetes, obesity, and sleep apnea is essential in managing AFib.

AFIB 59

AFIB Atrial Fibrillation Innovation Heart Rhythm 59

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Cardiometabolic Health Congress

DECEMBER 5, 2024

As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. Read the published study.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

DAIC

FEBRUARY 29, 2024

12:15 p.m.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

ADN Center of Excellence

SEPTEMBER 2, 2024

From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving. Risk Factor Management: Controlling risk factors such as hypertension, diabetes, obesity, and sleep apnea is essential in managing AFib.

AFIB 52

AFIB Atrial Fibrillation Innovation Heart Rhythm 52

ADN Center of Excellence

OCTOBER 28, 2024

Some of the latest strategies include: Innovations in Thrombolysis and Clot Retrieval : Techniques such as tissue plasminogen activator (tPA) injections and mechanical thrombectomy are significantly improving recovery rates for ischemic stroke patients.

Stroke 59

Stroke Strokes Education Innovation 59

Open Heart

JULY 10, 2023

The risk of AF was estimated using the FIND-AF (Future Innovations in Novel Detection of Atrial Fibrillation) risk score. to 13.01; 4.06), diabetes mellitus (123.3; We calculated cumulative incidence rates and fit Fine and Gray’s models at 1, 5 and 10 years for nine diseases and death adjusting for competing risks. 12.54, 12.08

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Cardiometabolic Health Congress

OCTOBER 26, 2023

Barb, MD MASLD, MASH and diabetes To explain the important implications of metabolic diseases like type 2 diabetes in the pathophysiology of MASLD and MASH, Diana D. National Institute of Diabetes and Digestive and Kidney Diseases. Barb, MD , took the podium to lend her experie nce from an endocrinology perspective. “It

Diabetes 52

Diabetes Kidney Disease Obesity Anatomy 52

SoftCath

OCTOBER 31, 2021

So, let’s unwind how the innovations in cath lab software are reshaping the method of cardiovascular care post-Covid-19. All of this resulted in the need for better and innovative cardiac care strategies that ensure better patient engagement and trust in digital medical infrastructure.

COVID-19 52

COVID-19 Innovation Cardiac Rehabilitation Cardiovascular Disease 52

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. Until this historic approval, no treatment existed.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

DECEMBER 19, 2023

This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

Cardiometabolic Health Congress

APRIL 12, 2024

Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heart disease remains the leading cause of death for men and women. 80% of heart attacks and strokes linked to CVD are preventable with optimal risk factor management.

Myocardial Infarction 64

Myocardial Infarction Cardiovascular Disease Heart Attack Heart attacks 64

Cardiometabolic Health Congress

AUGUST 2, 2023

Dr. Caballero is an endocrinologist, clinical investigator, and faculty director of International Innovation and Diabetes Education at Harvard Medical School. These conditions affect a patient’s risk of health conditions like heart disease, diabetes, and obesity. ” “But,” cautions Dr.

Education 40

Education Health Disparities Webinar Diabetes 40

Stroke Journal

FEBRUARY 1, 2024

Background:Acute hyperglycemia, which occurs in over 40% of ischemic stroke patients irrespective of pre-existing diabetes, exacerbates stroke injury. Understanding its mechanisms is vital for innovative treatments. Stroke, Volume 55, Issue Suppl_1 , Page AWMP115-AWMP115, February 1, 2024.

Stroke 40

Stroke Strokes Innovation Hemorrhage 40

Cardiometabolic Health Congress

AUGUST 2, 2024

This innovative approach integrates personal data from multiple biological layers to design bespoke dietary plans, transcending the limitations of one-size-fits-all recommendations. This is particularly beneficial in managing conditions like hypertension, where precise control of dietary sodium intake is crucial.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

DAIC

DECEMBER 26, 2023

The potential to detect aortic stenosis through our IH technology is an exciting development that brings us a step closer to achieving the MindMics purpose to one day eliminate heart failure as the leading cause of death globally (similar to what glucose monitoring has done to transform diabetes)." "We

Stenosis 59

Stenosis Technology Aortic Aortic valve 59

Dr. Malcolm Kendrick

JANUARY 12, 2023

But within a corrupt system, where the majority of funding comes from commercial sources, innovation grinds to a halt. Try stating that Type II diabetes can be reversed with exercise and a low carbohydrate diet, and you are threatening a $200Bn market for diabetes medications. Primarily because new ideas threaten profit.

Research 52

Research Cancer Innovation Academic 52

The Beat Blog

MAY 2, 2023

Specialty Demand Certain specialties, focused on conditions like cardiovascular disease and diabetes, also have rising demand, as the baby boomer population ages and becomes higher risk. That trip is often longer in more rural locations. which often suffer from higher poverty rates, too. Doing so also helps address socio-economic barriers.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52

Cardiometabolic Health Congress

JULY 7, 2023

I personally believe that although creativity and innovation are important, a lot of what we are able to achieve and contribute to is actually dependent on doing the right things that we know work and doing them on a consistent basis. 18-21, 2023.

Education 52

Education Research Quality of Life Academic 52

Journal of the American Heart Association

FEBRUARY 23, 2024

The aim was to determine the role of 4βHC as a prognostic factor in CAD.Methods and ResultsThe ARTEMIS (Innovation to Reduce Cardiovascular Complications of Diabetes at the Intersection) cohort consists of 1946 patients with CAD. Men and women were analyzed separately in quartiles according to plasma 4βHC.

Coronary Artery Disease 67

Coronary Artery Disease Sudden Cardiac Death Blood Pressure Diabetes 67

Wellnest

JULY 19, 2023

However, recent studies have observed that people below 40 are also experiencing heart attacks due to high blood pressure, cholesterol, diabetes, smoking, obesity, a sedentary lifestyle, and social and mental stress. Manage diabetes. Diabetes increases the risk of diabetic heart disease by a factor of two.

Heart Attack 52

Heart Attack Heart attacks Blood Pressure Myocardial Infarction 52

Stroke Journal

JANUARY 30, 2025

proposed an innovative thromboembolic stroke model in mice where murine thrombin is injected into the M2 segment of the middle cerebral artery (MCA) to induce arterial thrombosis. It emerged as a sensitive but versatile and translationally tool for evaluating pharmacological efficacy and safety of innovative drugs.

Pharmacology 40

Pharmacology Stroke Strokes Thrombosis 40

Cardiometabolic Health Congress

MARCH 8, 2024

She researches strategies to treat diabetes mellitus and reduce the risk of cardiovascular, renal, and other diabetes-related complications. Peters, MD: Professor at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59